Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Solid Tumor Testing Market by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, and Cervical Cancer): Global Opportunity Analysis and Industry Forecast, 2017-2023

LI_184501

Pages: NA

Charts: NA

Tables: NA

Solid tumor testing is a procedure used to evaluate primary tumor and determine extent/location of any metastases. The tumor testing in turn allows effective treatment options to be considered so that the spread of cancerous cells can be avoided.

Increase in incidence of cancer and rise in funding support by various organizations drive the market. Moreover, growth in demand for personalized medicine also propels the market. However, stringent regulatory approval procedure restricts the market growth.

The global solid tumor testing market is segmented on the basis of cancer type and region. According to cancer type, the market is divided into breast cancer, lung cancer, colorectal cancer, prostate cancer, cervical cancer, and others. By geography, it is analyzed across four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.

The key companies of the solid tumor testing market include Abbott Laboratories, Agilent Technologies, 20/20 GeneSystems Inc., Thermo Fisher Scientific, Inc., Avant Diagnostics, Inc., Advanced Cell Diagnostics, Inc., Agena Bioscience, Inc., Bio-Rad Laboratories, Inc., Johnson & Johnson, and Biocare Medical, LLC.

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market assists in understanding the regional trends.
  • Key players and their strategies are analyzed to understand the competitive outlook of the market.

Solid Tumor Testing Market Key Segments:

By Cancer Type

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

CHAPTER 1 INTRODUCTION

1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Research Methodology

1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Analyst Tools and Models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO Perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Porter’s Five Forces Analysis
3.3 Market Share Analysis, 2016
3.4 Market Dynamics

3.4.1 Drivers
3.4.2 Restraints
3.4.3 Opportunities

CHAPTER 4 SOLID TUMOR TESTING MARKET, BY CANCER TYPE

4.1 Overview
4.2 Market size and forecast
4.3 Breast Cancer

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 Lung Cancer

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

4.5 Colorectal Cancer

4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast

4.6 Prostate Cancer

4.6.1 Key market trends
4.6.2 Key growth factors and opportunities
4.6.3 Market size and forecast

4.7 Cervical Cancer

4.7.1 Key market trends
4.7.2 Key growth factors and opportunities
4.7.3 Market size and forecast

4.8 Others

4.8.1 Key market trends
4.8.2 Key growth factors and opportunities
4.8.3 Market size and forecast

CHAPTER 5 SOLID TUMOR TESTING MARKET, BY REGION

5.1 Overview

5.1.1 Market size and forecast

5.2 North America

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast

5.2.3.1 U.S. market size and forecast
5.2.3.2 Canada market size and forecast
5.2.3.3 Mexico market size and forecast

5.3 Europe

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast

5.3.3.1 Germany market size and forecast
5.3.3.2 France market size and forecast
5.3.3.3 UK market size and forecast
5.3.3.4 Italy market size and forecast
5.3.3.5 Spain market size and forecast
5.3.3.6 Rest of Europe market size and forecast

5.4 Asia-Pacific

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast

5.4.3.1 Japan market size and forecast
5.4.3.2 China market size and forecast
5.4.3.3 India market size and forecast
5.4.3.4 Australia market size and forecast
5.4.3.5 Rest of Asia-Pacific market size and forecast

5.5 LAMEA

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast

5.5.3.1 Brazil market size and forecast
5.5.3.2 South Africa market size and forecast
5.5.3.3 Saudi Arabia market size and forecast
5.5.3.4 Rest of LAMEA market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1 Abbott Laboratories

6.1.1 Overview
6.1.2 Company snapshot
6.1.3 Business performance
6.1.4 Operating segment overview
6.1.5 Strategic moves and developments

6.2 Agilent Technologies

6.2.1 Overview
6.2.2 Company snapshot
6.2.3 Business performance
6.2.4 Operating segment overview
6.2.5 Strategic moves and developments

6.3 20/20 GeneSystems Inc.

6.3.1 Overview
6.3.2 Company snapshot
6.3.3 Business performance
6.3.4 Operating segment overview
6.3.5 Strategic moves and developments

6.4 Thermo Fisher Scientific, Inc.

6.4.1 Overview
6.4.2 Company snapshot
6.4.3 Business performance
6.4.4 Operating segment overview
6.4.5 Strategic moves and developments

6.5 Avant Diagnostics, Inc.

6.5.1 Overview
6.5.2 Company snapshot
6.5.3 Business performance
6.5.4 Operating segment overview
6.5.5 Strategic moves and developments

6.6 Advanced Cell Diagnostics, Inc.

6.6.1 Overview
6.6.2 Company snapshot
6.6.3 Business performance
6.6.4 Operating segment overview
6.6.5 Strategic moves and developments

6.7 Agena Bioscience, Inc.

6.7.1 Overview
6.7.2 Company snapshot
6.7.3 Business performance
6.7.4 Operating segment overview
6.7.5 Strategic moves and developments

6.8 Bio-Rad Laboratories, Inc.

6.8.1 Overview
6.8.2 Company snapshot
6.8.3 Business performance
6.8.4 Operating segment overview
6.8.5 Strategic moves and developments

6.9 Johnson & Johnson

6.9.1 Overview
6.9.2 Company snapshot
6.9.3 Business performance
6.9.4 Operating segment overview
6.9.5 Strategic moves and developments

6.10 Biocare Medical, LLC

6.10.1 Overview
6.10.2 Company snapshot
6.10.3 Business performance
6.10.4 Operating segment overview
6.10.5 Strategic moves and developments

Purchase Full Report of
Solid Tumor Testing Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 60% discount on subscription plans on


KNOWLEDGETREE